U.S. Alzheimer's Disease Medications Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

The U.S. Alzheimer's Disease Medications market report provides revenue forecasts, patient forecasts, pricing forecasts, competitive analysis, market trends, and product analysis. The market is segmented into mild to moderate, moderate to severe, and mild cognitive impairment Alzheimer's disease. Each of the segments discusses discusses all these in detail along with product pipeline and competitive structure.

Table of Contents

U.S. Alzheimer's Disease Medications Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Alzheimer's Disease Medications Markets, Diagnosis and TreatmentIntroductionReport Scope and SegmentationDisease OverviewPrevalence and IncidenceClinical PresentationNeurological ImpactDiagnosisPharmacological TreatmentsPharmacological Treatments GuidelinesCognitive TreatmentsBehavioral TreatmentsPreventative TreatmentsU.S. Alzheimer's Disease Medications Markets, Total Alzheimer's Disease Medications MarketOverviewIntroductionCurrent Treatments and Market ParticipantsTop Industry ChallengesDemand AnalysisTotal Prevalence ForecastsAdjusted Prevalence ForecastsDemand Analysis: Conclusions and ImplicationsHistorical Market Analysis:1998-2002Market DynamicsProduct AnalysisProduct Pricing AnalysisTechnology and Market TrendsResearch and Development ActivitiesResearch and Development Areas of FocusAcetylcholinesterase InhibitorsNon-Steroidal Anti-Inflammatory Drugs (NSAIDs)Estrogen Replacement Therapy/Hormone Replacement Therapy (ERT/HRT) Nerve Growth FactorsNMDA Receptor AntagonistsOther Research AreasPhase I to Phase III TrialsMarket Forecasts: 2003-2010Baseline Market Forecasts: 2003-2010Market Drivers and its Impact on Future RevenuesMarket Restraints and Its Impact on Future RevenuesEvent-Based ForecastsMarket Engineering AnalysisFrost & Sullivan AwardsProduct Approval and Entry Strategy AwardDisease Education and Awareness Promotion AwardNovel Technology Innovation AwardU.S. Alzheimer's Disease Medications Markets, Mild to Moderate Alzheimer's Disease Medications MarketSegment HighlightsSegment HighlightsMarket DynamicsCurrent MarketTop Industry ChallengesTop Market DriversTop Market RestraintsMarket Revenue Forecasts: 2003-2010Baseline ForecastResearch and Development ActivitiesEvent Based ForecastMarket Engineering AnalysisU.S. Alzheimer's Disease Medications Markets, Moderate to Severe Alzheimer's Disease Medications MarketSegment HighlightsSegment HighlightsMarket DynamicsCurrent MarketTop Industry ChallengesTop Market DriversTop Market RestraintsMarket Revenue Forecast: 2003-2010Baseline ForecastResearch and Development ActivitiesEvent-based ForecastMarket Engineering AnalysisU.S. Alzheimer's Disease Medications Markets, Mild Cognitive Impairment Alzheimer's Disease Medications MarketSegment HighlightsSegment HighlightsMarket DynamicsCurrent MarketTop Industry ChallengesTop Market DriversTop Market RestraintsMarket Revenue Forecast: 2003-2010Baseline ForecastResearch and Development ActivitiesEvent-based ForecastMarket Engineering AnalysisU.S. Alzheimer's Disease Medications Markets, Physician SurveyPhysician SurveyPhysician SurveyU.S. Alzheimer's Disease Medications Markets, AppendixDecision Support DatabaseNumber of Alzheimer's PatientsPsychiatristsNeurologistsMale Population 65 and AboveFemale Population 65 and Above




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.